BCR DIAGNOSTICS, INC.

Basic Information

1123 E. THUNDERHILL PL
PHOENIX, AZ, 85048-

Company Profile

n/a

Additional Details

Field Value
DUNS: 10620297
Hubzone Owned: N
Socially and Economically Disadvantaged: Y
Woman Owned: N
Number of Employees: n/a


  1. Ultrasensitive Detection of Hepatitis Viruses by Immunoassay Amplification

    Amount: $145,637.00

    DESCRIPTION (provided by applicant): This proposal responds to the action plan for combating the Silent Epidemic of Viral Hepatitis recently launched by the National Institutes of Health by focusing ...

    SBIR Phase I 2013 Department of Health and Human Services
  2. Engineered Spores as Fluorogenic Biological Indicators for Sterility Testing

    Amount: $699,007.00

    DESCRIPTION (provided by applicant): BCR Diagnostics, Inc. (BCR) has recently developed and patented a technology platform for engineering fluorogenic functionality into living Bacillus spores. Fluoro ...

    SBIR Phase II 2008 Department of Health and Human Services
  3. Engineered Spores as Fluorogenic Biological Indicators for Sterility Testing

    Amount: $99,930.00

    DESCRIPTION (provided by applicant): BCR Diagnostics, Inc. (BCR) has recently developed and patented a technology platform for engineering fluorogenic functionality into living Bacil ...

    SBIR Phase I 2007 Department of Health and Human Services
  4. LOW-COST BIOSENSOR FOR REAL-TIME DIAGNOSIS OF BACTEREMIA

    Amount: $137,221.00

    DESCRIPTION (provided by applicant): BCR Diagnostics, Inc. (BCR) proposes to study the feasibility of applying its low-cost biosensor technology to detecting bacteremia in real-time (i.e., less than ...

    SBIR Phase I 2004 Department of Health and Human Services
  5. REAL TIME DETECTION OF BACTERIA IN PLATELET CONCENTRATES

    Amount: $739,219.00

    DESCRIPTION (provided by applicant): Bacterial contamination of blood products is currently a major problem in transfusion medicine and a leading cause of transfusion-related deaths. Platelets are pa ...

    SBIR Phase II 2003 Department of Health and Human Services
  6. REAL-TIME DETECTION OF BACTERIA IN PLATELET CONCENTRATES

    Amount: $136,210.00

    DESCRIPTION (Provided by applicant): BCR Diagnostics, Inc. (BCR) proposes to demonstrate the feasibility of adapting its LEXSAS (Label-free Exponential Signal-Amplification System) technology for real ...

    SBIR Phase I 2002 Department of Health and Human Services
  7. Test for Occult Micrometastases in Primary Breast Cancer

    Amount: $62,336.00

    We will develop and validate a new assay system to replace existing immunocytochemicalassays for detecting occult micrometastases in bone marrow of patients with primary breast cancer.This assay would ...

    SBIR Phase I 1994 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government